Bamco Inc. NY acquired a new stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 153,615 shares of the biotechnology company's stock, valued at approximately $86,118,000. Bamco Inc. NY owned about 0.19% of Axon Enterprise at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in the company. BlackRock Inc. boosted its holdings in shares of Axon Enterprise by 4.3% in the second quarter. BlackRock Inc. now owns 8,334,551 shares of the biotechnology company's stock worth $4,672,432,000 after acquiring an additional 345,365 shares during the period. Geode Capital Management LLC raised its stake in shares of Axon Enterprise by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 2,226,159 shares of the biotechnology company's stock valued at $1,265,657,000 after purchasing an additional 35,544 shares during the period. Sands Capital Management LLC lifted its holdings in Axon Enterprise by 11.6% during the 4th quarter. Sands Capital Management LLC now owns 1,609,436 shares of the biotechnology company's stock worth $914,047,000 after purchasing an additional 167,095 shares in the last quarter. Wellington Management Group LLP lifted its holdings in Axon Enterprise by 326.9% during the 4th quarter. Wellington Management Group LLP now owns 1,539,738 shares of the biotechnology company's stock worth $874,463,000 after purchasing an additional 1,179,038 shares in the last quarter. Finally, Edgewood Management LLC bought a new position in Axon Enterprise in the 4th quarter worth about $846,516,000. Hedge funds and other institutional investors own 79.08% of the company's stock.
Axon Enterprise Price Performance
Shares of AXON stock opened at $607.48 on Thursday. The business's fifty day moving average is $553.45 and its 200 day moving average is $480.77. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47. The stock has a market cap of $49.35 billion, a price-to-earnings ratio of 252.07, a PEG ratio of 9.95 and a beta of 1.39. Axon Enterprise, Inc has a twelve month low of $339.01 and a twelve month high of $794.29.
Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The firm had revenue of $904.39 million during the quarter, compared to analyst estimates of $876.42 million. During the same period last year, the business earned $2.12 earnings per share. The business's revenue was up 35.3% on a year-over-year basis. Research analysts expect that Axon Enterprise, Inc will post 2.04 EPS for the current fiscal year.
Insider Transactions at Axon Enterprise
In other news, insider Elizabeth Reid Coughlin sold 1,554 shares of the firm's stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $485.00, for a total transaction of $753,690.00. Following the sale, the insider owned 34,024 shares of the company's stock, valued at $16,501,640. This trade represents a 4.37% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Patrick W. Smith sold 20,000 shares of Axon Enterprise stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $500.00, for a total transaction of $10,000,000.00. Following the completion of the sale, the chief executive officer owned 3,060,997 shares of the company's stock, valued at $1,530,498,500. This represents a 0.65% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 76,594 shares of company stock valued at $41,236,386. Insiders own 4.20% of the company's stock.
Analyst Upgrades and Downgrades
AXON has been the topic of several recent analyst reports. Citizens Jmp reiterated a "market outperform" rating and issued a $700.00 target price on shares of Axon Enterprise in a research note on Thursday, June 25th. Morgan Stanley increased their price objective on Axon Enterprise from $600.00 to $640.00 and gave the stock an "overweight" rating in a research report on Thursday, August 6th. Needham & Company LLC reissued a "buy" rating on shares of Axon Enterprise in a research note on Thursday, August 6th. Royal Bank Of Canada restated an "outperform" rating on shares of Axon Enterprise in a research report on Tuesday, July 21st. Finally, Piper Sandler raised their price target on Axon Enterprise from $724.00 to $732.00 and gave the company an "overweight" rating in a report on Thursday, August 6th. Thirteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, Axon Enterprise currently has an average rating of "Moderate Buy" and a consensus target price of $730.92.
View Our Latest Research Report on Axon Enterprise
About Axon Enterprise
(
Free Report)
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company's hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Featured Articles
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
